Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Interest Coverage Ratio (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Interest Coverage Ratio for 4 consecutive years, with 18.61 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Coverage Ratio fell 2.56% to 18.61 in Q3 2025 year-over-year; TTM through Sep 2025 was 19.21, a 20.98% decrease, with the full-year FY2024 number at 19.93, down 15.24% from a year prior.
  • Interest Coverage Ratio was 18.61 for Q3 2025 at Centessa Pharmaceuticals, up from 18.95 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 10.7 in Q1 2025 to a low of 41.39 in Q2 2022.
  • A 4-year average of 21.27 and a median of 18.89 in 2022 define the central range for Interest Coverage Ratio.
  • Peak YoY movement for Interest Coverage Ratio: soared 53.63% in 2023, then crashed 119.79% in 2024.
  • Centessa Pharmaceuticals' Interest Coverage Ratio stood at 18.89 in 2022, then grew by 27.55% to 13.69 in 2023, then plummeted by 119.79% to 30.08 in 2024, then skyrocketed by 38.13% to 18.61 in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Interest Coverage Ratio are 18.61 (Q3 2025), 18.95 (Q2 2025), and 10.7 (Q1 2025).